Corcept Therapeutics (CORT) Change in Acquisitions & Divestments (2017 - 2026)

Corcept Therapeutics has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $57.1 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $57.1 million, down 49.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $334.6 million (down 26.64% YoY), and the FY2025 annual result was $389.6 million, down 5.64% from the prior year.
• Change in Acquisitions & Divestments came in at $57.1 million for Q1 2026 at Corcept Therapeutics, down from $132.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $207.5 million in Q1 2023 to a low of $42.1 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $79.4 million (2022), against an average of $89.4 million.
• Across the five-year window, Change in Acquisitions & Divestments soared 392.5% in 2023 and plunged 71.23% in 2025, its largest moves.
• Corcept Therapeutics' Change in Acquisitions & Divestments stood at $79.4 million in 2022, then sank by 40.83% to $47.0 million in 2023, then jumped by 70.92% to $80.3 million in 2024, then soared by 64.37% to $132.0 million in 2025, then slumped by 56.78% to $57.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $57.1 million (Q1 2026), $132.0 million (Q4 2025), and $52.0 million (Q3 2025), per Business Quant data.